ChemoCentryx
CCXI
#3559
Rank
ยฃ2.80 B
Marketcap
ยฃ39.04
Share price
0.00%
Change (1 day)
28.03%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -ยฃ0.11 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are ยฃ37.2 Million. In 2021 the company made an earning of -ยฃ96.92 Million a decrease over its 2020 earnings that were of -ยฃ39.59 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -ยฃ0.11 Billion3.25%
2021 -ยฃ96.92 Million144.84%
2020 -ยฃ39.59 Million-1.18%
2019 -ยฃ40.06 Million45.17%
2018 -ยฃ27.6 Million-305.69%
2017 ยฃ13.41 M-144.7%
2016 -ยฃ30.02 Million-15.52%
2015 -ยฃ35.53 Million0.85%
2014 -ยฃ35.23 Million21.47%
2013 -ยฃ29 Million-1.24%
2012 -ยฃ29.37 Million906.88%
2011 -ยฃ2.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
ยฃ1.42 B-1,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.24 B-1,371.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ7.00 B-7,238.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
ยฃ6.03 B-6,250.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.32 B-24,905.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.19 B-6,412.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.90 B-9,175.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.33 B-1,456.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
ยฃ17.33 B-17,779.94%๐Ÿ‡บ๐Ÿ‡ธ USA